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a b s t r a c t
Redox control of proteins that form disulﬁde bonds upon oxidative challenge is an emerging topic in the
physiological and pathophysiological regulation of protein function. We have investigated the role of the
neuronal calcium sensor protein visinin-like protein 1 (VILIP-1) as a novel redox sensor in a cellular
system. We have found oxidative stress to trigger dimerization of VILIP-1 within a cellular environment
and identiﬁed thioredoxin reductase as responsible for facilitating the remonomerization of the dimeric
protein. Dimerization is modulated by calcium and not dependent on the myristoylation of VILIP-1.
Furthermore, we show by site-directed mutagenesis that dimerization is exclusively mediated by Cys187.
As a functional consequence, VILIP-1 dimerization modulates the sensitivity of cells to an oxidative
challenge. We have investigated whether dimerization of VILIP-1 occurs in two different animal models
of amyotrophic lateral sclerosis (ALS) and detected soluble VILIP-1 dimers to be signiﬁcantly enriched in
the spinal cord from phenotypic disease onset onwards. Moreover, VILIP-1 is part of the ALS-speciﬁc
protein aggregates. We show for the ﬁrst time that the C-terminus of VILIP-1, containing Cys187, might
represent a novel redox-sensitive motif and that VILIP-1 dimerization and aggregation are hallmarks of
ALS. This suggests that VILIP-1 dimers play a functional role in integrating the cytosolic calcium
concentration and the oxidative status of the cell. Furthermore, a loss of VILIP-1 function owing to
protein aggregation in ALS could be relevant in the pathophysiology of the disease.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
In addition to the detrimental damage to biomolecules mediated
by reactive oxygen species (ROS)1, oxidative modiﬁcations by
distinct ROS such as hydrogen peroxide (H2O2) regulate protein
structure and function in a physiological manner [1]. One of these
modiﬁcations is the formation of inter- and intramolecular disulﬁde
bonds of cytosolic proteins that serve as redox sensors and regulate
a wide range of cellular processes. Among those are transcription
factors such as Yes-associated protein 1 (Yap1) [2], molecular
chaperones, and translation factors, as well as proteins involved in
energy metabolism, signal transduction, and apoptosis [3]. How-
ever, relatively little is known about the nature of regulatory
cysteine sites in proteins and whether these sites share any
common characteristics [4].
Members of the neuronal calcium sensor (NCS) protein family,
such as visinin-like protein 1 (VILIP-1), possess highly conserved
cysteine residues. These proteins are predominantly neuronally
expressed calcium sensors belonging to the superfamily of
EF-hand calcium-binding proteins that are involved in a variety
of cellular processes [5]. Many members of the NCS protein family
perform a so-called calcium–myristoyl switch upon calcium bind-
ing, releasing the myristoyl residue from a hydrophobic pocket
inside the protein and thus allowing the relocation of the protein
from the cytosol to cellular membranes [6–8]. VILIP-1 belongs to
the visinin-like protein subfamily (class B) of the NCS family,
which overall comprises 14 genes [9]. It is extraordinarily con-
served from zebraﬁsh to human, indicating that this protein has a
crucial function in vertebrates. VILIP-1 is 191 amino acids long and
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binds two calcium ions [10] in a cooperative manner, with calcium
binding ﬁrst to the high-afﬁnity EF-hand 3 binding site and
subsequently to the EF-hand 2 binding site [11]. VILIP-1 possesses
three cysteine residues at positions Cys38, Cys87, and Cys187, with
Cys87 being present exclusively in VILIP-1 and VILIP-2, and not in
other class B family members. Based on data from in vitro
experiments, it is controversial whether VILIP-1 is able to dimerize
by covalent interactions and whether calcium binding triggers
dimer formation [11–13].
VILIP-1 has been shown to be involved in a variety of cellular
functions. There is compelling evidence that VILIP-1 is involved in
clathrin-dependent receptor trafﬁcking and exocytosis by modu-
lating the surface expression of transmembrane receptors, thereby
increasing cellular cGMP and cAMP levels [14–20]. VILIP-1 was
also described to bind double-stranded RNA [21] and has been
shown to act as a tumor suppressor by inhibiting cell proliferation
and migration [22–24]. Furthermore, there is evidence that VILIP-1
is involved in long-term potentiation and synaptic plasticity [25].
Altered VILIP-1 expression and localization have been described in
Alzheimer disease (AD) and schizophrenia [26–28]. Moreover,
downregulation of VILIP-1 has been reported in amyotrophic
lateral sclerosis (ALS) [29].
ALS is a progressive, late-onset neurodegenerative disease
leading to the loss of motor neurons in the spinal cord, the brain
stem, and the motor cortex. It is characterized by intracellular
protein aggregates, glial activation, mitochondrial dysfunction, and
perturbed calcium homeostasis. The increased presence of ROS in
the course of disease owing to misregulation of NADPH oxidases,
mitochondrial damage, and downregulation of antioxidative
enzymes has been determined as one of the prominent cytotoxic
components in ALS [30–32]. In addition, calcium homeostasis
within motor neurons is particularly susceptible to insult because
of low levels of calcium binding proteins [33–35]. An increased
calcium uptake induced by elevated extracellular glutamate levels,
which are caused by reduced astrocytic glutamate uptake [36–39]
and by AMPA receptors lacking the GluR2 subunit [40,41], results
in excitotoxicity. This detrimental process is at least partially
mediated by an increased uptake of calcium into mitochondria,
which in turn results in elevated ROS production [42,43], indicat-
ing that oxidative stress and excitotoxicity enhance each other to
contribute to ALS pathology [44].
Here, we investigated whether VILIP-1 represents an oxidative
stress sensor in cells as well as in animal models of ALS. By site-
directed mutagenesis we provide evidence that VILIP-1 undergoes
reversible oxidative stress-induced dimerization that is mediated
by Cys187. We found dimerization of VILIP-1 to strongly depend
on calcium, but not on protein relocation due to its myristoyl
residue. By employing survival assays we analyzed the impact of
VILIP-1 dimerization and myristoylation on the sensitivity of cells
to an oxidative challenge. Finally, the analysis of tissues from two
different rodent models of ALS showed that VILIP-1 dimer forma-
tion correlates with disease progression. Based on our data we
propose that VILIP-1 is a redox sensor that integrates Ca2þ
homeostasis and the level of oxidative stress within a cell.
Furthermore, the presence of disease-related VILIP-1 dimers and
aggregates points to a possible role of VILIP-1 in the progression of
motor neuron disease.
Materials and methods
Animals
Mice were kept in the animal facility of the University Medical
Center (ZVTE) and were housed, anesthetized, and sacriﬁced
according the state law of Rheinland-Pfalz and European and
German guidelines for the care and use of laboratory animals.
Mice overexpressing human wild-type SOD1 (hSOD1WT; B6/SJFL/
TgN(SOD1)-2Gur), the hSOD1G93A mutant with low copy number
(hSOD1G93A; B6/SJL/TgN(SOD1-G93A)-Gur) (The Jackson Labora-
tory, Bar Harbor, ME, USA), and the human SOD1G85R (hSODG85R)
mutant were kept hemizygous, and nontransgenic littermates
served as controls. Disease onset was deﬁned when the maximum
body weight was reduced by 10% (260 and 331 days of age for
hSOD1G93A and hSOD1G85R, respectively). End stage of disease was
deﬁned as when the mice were not able to right themselves up
within 10 s when laid on the side (298 and 369 days of age for
hSOD1G93A and hSOD1G85R, respectively). Owing to the differences
in survival of hSOD1G93A and hSOD1G85R transgenic mice,
presymptomatic mice were analyzed at 4 and 7 months of age,
respectively.
Spinal cord tissues from hSOD1 transgenic rats were kindly
provided by Drs. S. Boillee and C. Lobsiger (Paris, France).
Generation of VILIP-1 constructs
VILIP-1 without green ﬂuorescent protein (GFP) was ampliﬁed
from a plasmid carrying the human wild-type VILIP-1–GFP (VILIP-
1WT-GFP) in pEGFPN1 (gift from Professor K.H. Braunewell, Bir-
mingham, AL, USA) with primers spanning the BglII and SalI
restriction sides (see Supplementary Table 1) and ligated into a
modiﬁed pEGFP-N1 (Clontech) vector without EGFP (pN1). From
this vector, VILIP-1 without GFP was inserted into the pEF-BOS-EX
vector (gift from Professor S. Nagata, Kyoto, Japan [45,46]) using
the NheI and the SalI restriction sides.
Point mutations (G2A, C38A, C87A, C187A) were inserted into
VILIP-1WT in pEF-BOS-EX using the Quick Change Lightning site-
directed mutagenesis kit (Agilent Technologies). The sequences of
suitable forward and reverse primers for mutagenesis can be
viewed in Supplementary Table 2. To ensure correct insertion of
the point mutations, the plasmids were sequenced (Genterprise,
Mainz, Germany).
Cell culture
Human embryonic kidney cells 293 A (HEK293A) were culti-
vated on plastic dishes with Dulbecco’s modiﬁed Eagle’s medium
(DMEM; Life Technologies) supplemented with fetal calf serum
(10%), 1% sodium pyruvate (Life Technologies), and antibiotics.
Cells were cultivated at 37 1C in a humidiﬁed atmosphere contain-
ing 5% CO2. For transient transfection the calcium phosphate
precipitation method was applied, which is detailed in the
supplementary material.
In the case of short-term incubations (2 to 90 min), H2O2,
diamide, N-acetylcysteine, auranoﬁn, ionomycin (all from Sigma–
Aldrich), MG-132 (Calbiochem), or BAPTA (Life Technologies) was
added in the appropriate concentration directly into the medium
48 h posttransfection and incubated for the indicated time inter-
vals. In the case of overnight preincubation with auranoﬁn, the
substance was added to the medium 24 h after transfection after
washing the cells. Dishes were placed on ice and washed twice
with phosphate-buffered saline (PBS) before harvest. Cell pellets
were stored at 80 1C until homogenization.
For recovery experiments cells were incubated with H2O2 or
vehicle for 2 min. Subsequently, the cells were either harvested or
washed twice with DMEM and supplemented with fresh medium
without H2O2. The cells were allowed to recover for either 30 min
or 2 h. If the impact of MG-132 or auranoﬁn on recovery was
tested, cells were preincubated with the substance or vehicle for
the indicated time intervals. Additionally, MG-132, auranoﬁn, or
vehicle was added to the fresh medium during recovery.
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Viability assays (MTT assays)
A calcium phosphate transfection method for cell suspensions
was performed. A transfection mixture containing 60 mg plasmid
DNA was prepared as described above and gently mixed with
4.4 ml cell suspension containing 300,000 cells. Five thousand
cells in 90 ml were plated per well in a 96-well plate. The
transfection efﬁciency was tested in parallel experiments conﬁrm-
ing comparable efﬁciency between different constructs via Wes-
tern blot analysis (data not shown). Twenty-four hours after
seeding, transfection mediumwas removed, the cells were washed
with DMEM, and 90 μl of fresh medium was added. Subsequently,
10 μl of various H2O2 dilutions in medium was added for 18 h. In
each experiment, 6 wells were treated with the same H2O2
concentration. Viability was evaluated by the MTT assay, which
is detailed in the supplementary material.
Extraction and fractionation of cells and tissues
To analyze total lysates, HEK293A cells were sonicated for 30 s
on ice in lysis buffer (100 mM NaCl, 50 mM Tris–HCl, 0.5% NP-40;
pH 8.0) containing 10 mM iodoacetamide (Sigma–Aldrich) and
EDTA-free protease inhibitor cocktail (Roche).
The experimental procedure performed to separate homoge-
nates of animal tissue into a soluble and an ALS-speciﬁc aggregate
fraction was described earlier [47] and is speciﬁed in the supple-
mentary material.
SDS–PAGE and Western blotting
Cell lysates (15 mg) and tissue extracts (5 mg) were separated by
SDS–PAGE on 12 or 15% polyacrylamide gels under reducing and
nonreducing conditions by adding loading buffer with or without
β-mercaptoethanol, respectively. Proteins were transferred to
nitrocellulose membranes and speciﬁcally detected by antibodies
recognizing VILIP-1 (Proteintech Europe), hSOD1 (NCL Novocas-
tra), ubiquitin (DAKO), and tubulin (Sigma–Aldrich). Secondary
antibodies binding mouse or rabbit IgG coupled to horseradish
peroxidase (Dianova) were used to develop the Western blots with
the LAS 3000 Intelligent Darkboxx (Fuji). Band intensities were
quantiﬁed with the AIDA Image Analyzer software (Raytest).
Details are described in the supplementary material.
Immunocytochemistry and microscopy
HEK293A cells were grown on glass coverslips in six-well
plates and transfected with VILIP-1 constructs, washed, and
treated with substances as described above. Cells were ﬁxed
(95% ethanol, 5% acetic acid) for 7 min at 20 1C, washed with
PBS, and incubated with antibodies against VILIP-1 (Proteintech
Europe) (1:200 in PBS with 10% fetal calf serum) for 2 h at room
temperature. Cells were incubated with a cyanine-conjugated
secondary antibody (anti-rabbit-Cy2; Jackson Immunoresearch
Laboratories) for 1 h at room temperature. After the cells were
washed, DAPI (0.5 mg/ml) was added for nuclear staining. Micro-
scopic analysis was performed with an inverted Axiovert 200
microscope (Zeiss) equipped with a SPOT RT CCD camera from
Diagnostic Instruments (Visitron).
Label-free LC–MSE mass spectrometry
Insoluble fractions of total spinal cords were prepared for
subsequent analysis with label-free LC–MSE (data-independent
liquid chromatography/mass spectrometry) as described earlier
and speciﬁed in the supplementary material [48].
Mass spectrometric analysis of the insoluble fraction was per-
formed with a Q-TOF tandem mass spectrometer as described in
[49]. Homogenization of three spinal cords, fractionation of the
lysate, and label-free mass spectrometry were performed twice for
each genotype, generating two biological replicates. Each lysate was
analyzed in ﬁve technical replicates and only proteins that were
detected at least three times were considered for further analysis.
Additionally, we regarded proteins to be enriched in an ALS-speciﬁc
manner only if we found them, in both hSOD1mutant mouse strains
(hSOD1G93A and hSOD1G85R), to be enriched in the insoluble
fractions by at least 50% with respect to both controls (nontrans-
genic, hSOD1WT). Furthermore, only proteins fulﬁlling the described
criteria in both biological replicates were considered.
Statistical analysis
Densitometric analyses of Western blots from two groups of
interest were compared by t test for independent samples.
Survival curves from viability assays were compared by two-way
analysis of variance and an all pairwise multiple comparison
procedure (Holm–Sidak method). A probability of error less than
5% (po0.05) was regarded as statistically signiﬁcant and less than
1% (po0.01) as highly signiﬁcant. Statistical analysis was per-
formed with SPSS (densitometric analysis) and SigmaStat (viability
assays).
Results
Oxidative stress induces dimerization of VILIP-1
As protein dimerization is a major factor controlling protein
function in vivo, we aimed to investigate whether VILIP-1, which
has been reported to dimerize in a cell-free system [12], could act
as a novel redox sensor. We transfected HEK293A cells not
expressing VILIP-1 endogenously with VILIP-1WT and treated them
with various concentrations of H2O2 for various time intervals.
Under nonreducing analytical conditions, we observed a signiﬁ-
cant proportion of VILIP-1WT to dimerize in a concentration- and
time-dependent manner, corresponding to a 44-kDa band on the
Western blot. Heterodimers of VILIP-1 with other proteins, which
would be detectable as bands of different sizes, did not form,
indicating the speciﬁcity of the homodimerization. Under reducing
conditions, only a single band corresponding to monomeric VILIP-
1WT (22 kDa) was detected (Fig. 1A). Dimerization occurred
rapidly, as 2 min of oxidative stimulus signiﬁcantly increased the
amount of VILIP-1WT dimer and was further enhanced when cells
were treated for up to 10 min (Fig. 1A). No morphological changes
or damage of the cells were observed after these incubation
intervals (Supplementary Fig. 1A). The acute induction of VILIP-1
dimers is a general response to thiol oxidative stress, as diamide
also induced VILIP-1 dimerization in a dose-dependent manner
(Supplementary Fig. 1B).
If the dimerization of VILIP-1 was caused by a direct oxidative
effect, dimerization should be attenuated by preincubation with a
thiol-based antioxidant before the oxidative challenge. To test this,
we preincubated VILIP-1WT-transfected cells with N-acetylcysteine
before treating them with H2O2. We detected signiﬁcantly less
VILIP-1 dimer formation compared to controls not pretreated with
N-acetylcysteine (Fig. 1B).
To control whether the band at 44 kDa refers to a VILIP-1
homodimer, we treated VILIP-1WT-GFP (51 kDa)-overexpressing
cells with H2O2. Treatment of VILIP-1WT-GFP-transfected cells
with H2O2 indeed resulted in a speciﬁc band with a size 4100
kDa (Supplementary Fig. 1C), conﬁrming that the observed
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modiﬁcation of VILIP-1 upon oxidative challenge represents a
homodimer of two VILIP-1 molecules, mediated by a disulﬁde
bond.
Dimerization of VILIP-1 can be reversed by the thioredoxin system
If the VILIP-1 dimer acts in cellular signaling, one would expect
that dimer formation is reversible. To test this, we challenged
VILIP-1WT-transfected cells with H2O2 for 2 min and allowed cells
to recover for either 30 min or 2 h in H2O2-free medium. Thirty
minutes of recovery were sufﬁcient to reduce the amount of VILIP-
1WT dimer signiﬁcantly, and after 2 h, the amount of VILIP-1WT
dimer was indistinguishable from that in untreated cells (Fig. 2).
Next we asked whether the loss of VILIP-1 dimer was either
due to degradation via the proteasome or due to speciﬁc remo-
nomerization of the dimer by a distinct cellular mechanism.
To investigate the ﬁrst possibility, we inhibited the proteasome
with MG-132 and allowed cells to recover for 30 min in H2O2-free
medium after oxidative stimulation. Polyubiquitinated proteins
were detected as a marker for proteasome inhibition. We observed
Fig. 1. Effects of oxidative stress on VILIP-1 dimerization. (A and B) VILIP-1WT-transfected HEK293A cells were treated with the indicated H2O2 concentrations for the
indicated time intervals. Cell lysis buffer was supplemented with iodoacetamide to block free SH groups of proteins to prevent dimerization of VILIP-1 during subsequent
analysis. 15 mg of total protein lysate was separated under nonreducing (β-ME) and reducing (þβ-ME) conditions (not shown for (B)) on 12% polyacrylamide gels and
analyzed on Western blots. To normalize for transfection efﬁciency, the ratio between VILIP-1 dimer and VILIP-1 monomer was calculated. (A) Ratio of VILIP-1 dimer vs
monomer was plotted against various H2O2 concentrations (upper graph) or incubation times (lower graph). The mean7SEM of three independent experiments is shown.
Treatment with 1 or 10 mM H2O2 for 10 min caused signiﬁcant dimerization of VILIP-1 (top). Dimerization of VILIP-1 was signiﬁcant already after 2 min of incubation with
10 mM H2O2 and still detectable after 30 min of incubation (bottom). (B) Cells were preincubated with either 10 mM N-acetylcysteine (NAC) or vehicle for 1 h before adding
10 mM H2O2 for 10 min. The VILIP-1 dimer/monomer ratio in cells incubated with 10 mM H2O2 for 10 min was normalized to 100%. The mean value of four independent
experiments7SEM is shown. Dimerization of VILIP-1 was signiﬁcantly reduced by preincubation with NAC. npo0.05, nnpo0.01.
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that neither VILIP-1 dimer formation nor removal under condi-
tions of proteasome inhibition was impaired (Fig. 3A). To investi-
gate a thiol-dependent mechanism potentially mediating the
re-monomerization of VILIP-1 dimers, the role of the thioredoxin
system was analyzed. We pretreated cells with the thioredoxin
reductase (TRXR) inhibitor auranoﬁn for either 15 h or 90 min to
analyze whether the removal of the VILIP-1 dimer was impaired
during recovery under conditions of TRXR inhibition. Owing to
auranoﬁn treatment, an increased dimer formation upon stimula-
tion with H2O2 was observed. We further found that the removal
of the VILIP-1 dimer was impaired when cells had been pretreated
with auranoﬁn (Fig. 3B). Therefore, we conclude that the
thior-edoxin system is involved in the remonomerization of
VILIP-1 dimers in vivo, providing a cellular switch to turn off
VILIP-1 dimer function when the redox environment changes to
more reducing conditions.
VILIP-1 dimerization is exclusively mediated by Cys187
VILIP-1 possesses three cysteine residues. Cys38 and Cys87 are
localized in the N-terminal region of the inactive EF-hand 1 and in
the C-terminal part of the EF-hand 2, respectively. Cys187 is not
part of an EF-hand and is localized in the C-terminus of VILIP-1
(Fig. 4A). To investigate the role of the individual cysteine residues
in dimer formation, we generated point mutations for each
cysteine residue, changing cysteine to alanine. We transfected
cells with VILIP-1WT, VILIP-1C38A, VILIP-1C87A, or VILIP-1C187A and
stimulated them with H2O2. We observed that VILIP-1C38A and
VILIP-1C87A dimerization in response to oxidative stress were not
altered compared to VILIP-1WT dimer formation, showing that
Cys38 and Cys87 are not involved in the dimerization. In the case
of transfection with VILIP-1C187A, no dimerization was induced by
H2O2 (Fig. 4B). These results show that the C-terminal residue
Cys187 is exclusively involved in the homodimerization of VILIP-1.
VILIP-1 dimerization is calcium-dependent, but does not require
membrane localization
VILIP-1 binds two calcium ions in a cooperative manner.
Calcium binding leads to the calcium–myristoyl switch of the
cytosolic protein and attaches VILIP-1 to the plasma membrane
and trans-Golgi membranes [50,51]. We aimed to investigate if
calcium binding and therefore a potential membrane localization
of VILIP-1 modulate the dimer formation. We found that in the
presence of ionomycin, which increases intracellular calcium
concentrations, oxidative VILIP-1 dimerization was enhanced in a
dose-dependent manner (Fig. 5A). In contrast, lowering the
intracellular calcium concentration with the membrane-
permeative calcium chelator BAPTA resulted in a reduced dimer
formation under oxidative conditions (Fig. 5B). It is of note that the
administration of ionomycin or BAPTA without the oxidative
challenge did not modify VILIP-1 dimerization (Figs. 5A and B).
These data suggest that calcium binding and the subsequent
reorganization of the protein structure facilitate dimer formation.
As calcium-bound VILIP-1 attaches to cellular membranes via
its N-terminal myristoyl residue, we wondered whether calcium-
dependent membrane localization is critical for dimerization. To
test this hypothesis, we generated a myristoyl-deﬁcient VILIP-1
mutant by changing Gly2 to an alanine (VILIP-1G2A). Interestingly,
VILIP-1G2A dimerized upon H2O2 treatment to an even higher
extent than VILIP-1WT (Fig. 6A) and ionomycin treatment further
enhanced this dimer formation (Fig. 6B). Moreover, also in cells
transfected with VILIP-1G2A, dimerization was suppressed after a
preincubation with BAPTA before oxidative stimulation (Fig. 6C).
This leads to the conclusion that dimerization of VILIP-1 depends
on calcium inducing major conformational changes in the protein
structure, but does not require the protein to be attached to
cellular membranes with its myristoyl residue.
To track the subcellular localization of VILIP-1WT, VILIP-1G2A,
and VILIP-1C187A, we visualized VILIP-1 in transfected cells after
treatment with either vehicle or H2O2 using immunoﬂuorescence
(Fig. 6D). Immunolabeling of VILIP-1 was speciﬁc, as we did not
detect any signal in empty-vector-transfected cells. We observed a
granular expression pattern for VILIP-1WT in the cytoplasm as well
as localization at the plasma membrane under control conditions.
Interestingly, the same pattern, namely a localization at the
plasma membrane, was also present in cells expressing VILIP-
1C187A and myristoyl-deﬁcient VILIP-1G2A. This shows that in our
system, a certain amount of VILIP-1 localizes to the plasma
membrane even in the absence of the myristoyl residue. Treat-
ment with H2O2 did not change the subcellular localization of
VILIP-1 notably.
Cys187-dependent VILIP-1 dimerization is a determinant of peroxide
cytotoxicity
To investigate whether the dimerization of VILIP-1 plays a
functional role in an oxidative environment, we exposed cells
Fig. 2. VILIP-1 dimerization induced by short-term oxidative challenge is completely reversible. VILIP-1-transfected cells were treated with 10 mM H2O2 for 2 min and
harvested directly or supplemented with fresh medium without H2O2 for the indicated time intervals. Total cell lysates (15 mg protein) were separated under nonreducing
(β-ME) and reducing (þβ-ME) conditions on 12% SDS–polyacrylamide gels and analyzed by Western blotting. The ratios of VILIP-1 dimer vs monomer were calculated to
normalize for transfection efﬁciency. The VILIP-1 dimer/monomer ratio after H2O2 treatment without recovery was set to 100%. The mean value of three independent
experiments7SEM is shown. After 2 h of recovery, the VILIP-1 dimer/monomer ratio was further reduced signiﬁcantly and indistinguishable from that in control cells.
Statistical signiﬁcance compared to control conditions without H2O2 exposure: npo0.05, nnpo0.01.
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transfected with VILIP-1WT, VILIP-1G2A, VILIP-1C187A, or empty
vector to a variety of physiologically relevant H2O2 concentrations
for 18 h. We found that VILIP-1WT overexpression signiﬁcantly
impaired the resistance of the cells to H2O2 compared to cells
transfected with empty-vector control. The same was observed
when the myristoyl-deﬁcient mutant VILIP-1G2A was expressed,
implying that the role of VILIP-1 in enhancing H2O2 sensitivity is
independent of its myristoyl residue. In contrast to this, no
increased H2O2 sensitivity was measured when cells were trans-
fected with VILIP-1C187A, lacking the residue critical for dimeriza-
tion (Fig. 7). Transfection efﬁciency was comparable between
transfections with different VILIP-1 constructs (not shown), ruling
out that the observed effect depended on different expression
levels. These ﬁndings demonstrate that dimerization of VILIP-1 in
response to oxidative stress might be involved in modulating
cellular viability and cell death.
Fig. 3. The role of the thioredoxin system in the remonomerization of VILIP-1 dimers. (A and B) Total cell lysates (15 mg protein) were separated under nonreducing (β-ME)
and reducing (not shown) conditions on 12% SDS–polyacrylamide gels and analyzed by Western blotting. The ratios of VILIP-1 dimer vs monomer were calculated to
normalize for transfection efﬁciency. The VILIP-1 dimer/monomer ratio after H2O2 treatment for 2 min without recovery was set to 100%. The mean values of (A) four and
(B) three independent experiments7SEM are shown. (A) VILIP-1WT-transfected HEK293A cells were preincubated with either 20 mM MG-132 or vehicle for 20 min before
adding 10 mM H2O2 for 2 min. Subsequently, the cells were either harvested or supplemented with fresh medium without H2O2 to recover in the presence or absence of
20 mM MG-132 for 30 min. Preincubation with MG-132 altered neither VILIP-1 dimerization in response to H2O2 (upper graph) nor the extend of recovery (lower graph).
(B) VILIP-1WT-transfected HEK293A cells were pretreated with 2 mM auranoﬁn (AF) or vehicle for either 90 min or 15 h before addition of 10 mM H2O2 for 2 min.
Subsequently, cells were either harvested or supplemented with fresh mediumwithout H2O2 to recover in the presence or absence of 2 mM AF for 30 min. Preincubation with
AF increased VILIP-1 dimerization in response to H2O2 compared to the vehicle-treated cells (upper graph). Recovery was impaired in cells preincubated with AF (for 15 h,
p¼0.083) (lower graph). npo0.05.
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VILIP-1 is dimerized in animal models of ALS
After noting that VILIP-1 displays several features of a redox
sensor in a cellular system, we were interested in whether
dimerization of VILIP-1 plays a role in vivo in animal models of
ALS. The presence of VILIP-1 dimers was investigated in extracts of
spinal cord and cerebellum after tissue fractionation of total
lysates, resulting in a soluble and an insoluble fraction enriched
in SDS-resistant protein aggregates. We ﬁrst analyzed the total
lysate and the soluble fraction, containing proteins of potential
functional relevance, in the presence and absence of reducing
agent for the occurrence of VILIP-1 dimers. In nontransgenic and
hSOD1WT-overexpressing mice, not developing an ALS pathology,
VILIP-1 dimers were hardly detectable in both fractions. In con-
trast, we found a signiﬁcant increase in VILIP-1 dimers already at
the onset of disease in spinal cords of mice expressing the ALS-
causing hSOD1G93A or hSOD1G85R mutant. Dimer formation in
spinal cord was also detected at disease end stage, but not in
cerebellum of affected animals (Figs. 8A–D). In presymptomatic
hSOD1mutant mice, VILIP-1 dimer levels were not elevated com-
pared to controls (Supplementary Fig. 3A). Prominent VILIP-1
dimer formation was also observed in the lumbar spinal cord of
rats expressing hSOD1G93A, but not in control animals
(Supplementary Fig. 4A). In both animal models, no VILIP-1 dimers
were detectable under reducing conditions, showing that the
dimer was formed owing to an intermolecular disulﬁde bond like
in HEK293A cells. Hence we have observed elevated steady-state
levels of the dimers in a tissue-speciﬁc and disease-stage-
dependent manner in animal models of ALS, a neurodegenerative
disease characterized by increased levels of oxidative stress and
elevated intracellular calcium.
VILIP-1 is enriched in ALS-speciﬁc protein aggregates
ALS is characterized by the formation of intracellular protein
aggregates. As we found VILIP-1 disulﬁde-linked dimers early
during the disease course, we aimed to investigate whether
VILIP-1 is also part of ALS-speciﬁc aggregates. Therefore, we
analyzed the aggregate-enriched fraction of the lumbar spinal
cord and the cerebellum of hSOD1G93A and hSOD1G85R mice and
age-matched controls. We used increasing amounts of detergents
to enrich detergent-insoluble proteins via centrifugation steps to
yield a fraction that remained insoluble in the presence of 0.5%
NP-40, 0.5% desoxycholate, and 0.25% SDS [47]. We calculated the
ratio of total protein in the aggregate-enriched fraction to total
protein in the soluble fraction, resulting in increased ratios
exclusively in the spinal cord, and not cerebellum, fraction of
hSOD1mutant mice at disease onset and disease end stage, showing
that this method is suitable for enriching proteins that aggregate
disease-dependently (Supplementary Fig. 2). Western blot analysis
of the aggregate-enriched fraction under reducing conditions
revealed VILIP-1 to be signiﬁcantly enriched in the spinal cord of
both hSOD1mutant mouse strains (Fig. 9A). VILIP-1 was present in
the aggregate-enriched fraction already at the onset of the disease.
Interestingly, under nonreducing conditions, we observed that the
additional amount of VILIP-1 in the aggregate-enriched fraction of
hSOD1mutant mice at disease end stage (and onset, not shown)
refers to high-molecular-mass species 4190 kDa (Fig. 9B, top). As
this smear was visible only under nonreducing conditions, VILIP-1
in this fraction seems to be aberrantly crosslinked via disulﬁde
bonds with itself and/or other proteins (Fig. 9B, bottom). No
aggregation of VILIP-1 was observed in the cerebellum of the
same mice (Fig. 9A). Furthermore, in presymptomatic mice, in
Fig. 4. VILIP-1 dimerization is mediated by Cys187. (A) Schematic representation of the primary protein structure of VILIP-1, highlighting the positions of the three cysteine
residues and the N-terminal glycine, which is part of the conserved myristoylation sequence. (B) HEK293A cells were transfected with VILIP-1WT, VILIP-1C38A, VILIP-1C87A, or
VILIP-1C187A. The cells were treated with either 10 mM H2O2 or vehicle for 10 min. 15 mg of total protein was separated under nonreducing (β-ME) and reducing (not
shown) conditions on 12% SDS–polyacrylamide gels and transferred to nitrocellulose membranes. To normalize for transfection efﬁciency, the VILIP-1 dimer/monomer ratio
was calculated and set to 100% in the case of VILIP-1WT. The mean value of three independent experiments7SEM is shown. Dimerization of VILIP-1C38A and VILIP-1C87A due
to oxidative treatment did not differ with respect to VILIP-1WT. No dimer formation occurred between VILIP-1C187A proteins. nnpo0.01.
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which we also failed to detect hSOD1mutant in the aggregate-
enriched fraction, no aggregation of VILIP-1 was detected, indicat-
ing that VILIP-1 and hSOD1mutant aggregate approximately at the
same time (Supplementary Fig. 3B). Moreover, we investigated the
aggregate-enriched fractions of spinal cords of hSOD1WT and
hSOD1G93A rats at the end stage of the disease. Also here, we
found VILIP-1 to aggregate ALS-speciﬁcally, showing that entrap-
ment of VILIP-1 in aggregates is not restricted to mouse models of
the disease (Supplementary Fig. 4B).
In a second approach, aiming to get deeper insight into the
composition of the protein aggregates in ALS mouse models, we
performed label-free LC–MSE mass spectrometry of insoluble
spinal cord fractions from hSOD1mutant mice at the end stage of
the disease and from age-matched controls. The quantitative
analysis revealed hSOD1mutant itself as well as ubiquitin to be
enriched in the insoluble fractions of both mouse models of ALS. In
addition to these proteins serving as positive controls, we found
VILIP-1 to be signiﬁcantly enriched in an ALS-speciﬁc manner
(Table 1).
To summarize these ﬁndings, VILIP-1 is prone to redox-
dependent crosslinking in two different animal models of ALS
speciﬁcally in the affected tissue beginning with the onset of the
disease. The observed aggregation pattern of VILIP-1 is comparable
with the aggregation pattern of hSOD1mutant.
Discussion
Speciﬁcity of VILIP-1 dimer formation and remonomerization
We have shown for the ﬁrst time in an intact cellular environ-
ment that disulﬁde-linked VILIP-1 homodimers form upon stimu-
lation with oxidants such as H2O2 or diamide in a time- and
concentration-dependent manner. This is in line with earlier
ﬁndings showing that VILIP-1 is able to dimerize via disulﬁde
bonds in vitro depending on the oxidative status [12,13]. We
demonstrate that Cys187 at the ﬂexible C-terminus exclusively
mediates disulﬁde bond formation in vivo, whereas Cys38 and
Cys87 do not contribute to dimerization. This is partly supported
by in vitro data showing that a mutation of Cys187 reduced, but
not completely prevented, dimer formation, indicating that in that
system also Cys38 and Cys87 were involved in disulﬁde bond
formation [12]. In this context it is remarkable that in the three-
dimensional structure of VILIP-1, Cys38 was shown to sit at the rim
of a hydrophobic cleft, being at least partially exposed [10]. The
lack of participation of Cys38 in dimer formation in vivo highlights
the speciﬁcity of the Cys187 interaction, as in the case of random
disulﬁde crosslinking, Cys38 should also be involved in dimer
formation. The speciﬁcity of VILIP-1 dimerization is strongly
supported by the formation of a distinct VILIP-1 dimer band after
Fig. 5. Modulation of VILIP-1 dimerization by calcium. (A and B) HEK293A cells transfected with VILIP-1WT were treated with 10 mM H2O2 for 10 min after a preincubation
with (A) the indicated ionomycin (IM) concentrations for 5 min, or (B) the indicated BAPTA concentrations for 35 min, or vehicle for the appropriate time intervals. 15 mg of
total protein was separated on nonreducing (β-ME) and reducing (not shown) 12% SDS–polyacrylamide gels and analyzed by Western blotting. The ratios of VILIP-1 dimer
to monomer were calculated to normalize for transfection efﬁciency. The VILIP-1 ratio from vehicle cells treated with H2O2 was set as 100%. The mean value7SEM is shown
for (A) three and (B) four independent experiments. Statistical analysis was performed within the H2O2-treated group between vehicle-treated cells and IM- or BAPTA-
treated cells. (A) The VILIP-1 dimer-to-monomer ratio was increased dependent on IM treatment. This was signiﬁcant according to treatment with 5 or 10 mM IM.
(B) Preincubation with 10, 40, or 100 mM BAPTA signiﬁcantly reduced the VILIP-1 dimer/monomer ratio. npo0.05, nnpo0.01.
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oxidative challenge, rather than the appearance of a smear in the
Western blot analysis.
All ﬁve NCS class B proteins (VILIP-1 to -3, hippocalcin, neuro-
calcin δ), but no other members of the NCS protein family, possess
the Cys187 residue. Therefore, Cys187-mediated dimerization could
be relevant in all NCS class B proteins. Earlier, the NCS class C protein
recoverin was proposed to be redox sensitive, dimerizing via
an intermolecular disulﬁde bond with the highly conserved
Cys38 residue under conditions of oxidative stress in vitro [52].
This dimerization was reversible and modulated by calcium.
In contrast to recoverin, Cys38 was not involved in dimerization of
VILIP-1. Moreover, a whole range of NCS proteins, including guanylyl-
cyclase activating protein-2, neurocalcin δ, and calsenilin (also
known as DREAM or KChIP3), undergo functional dimerization,
although in these cases dimerization was mediated by noncovalent
interactions [53–55]. Recently, noncovalent dimerization has also
been proposed for VILIP-1 [11,13]. We suggest that noncovalently
linked dimers of VILIP-1 might act as precursors for the speciﬁc
Fig. 6. VILIP-1 dimerization of a myristoyl-deﬁcient VILIP-1 mutant. (A–C) HEK293A cells transfected with (A) VILIP-1WT or (A–C) VILIP-1G2A were treated with 10 mM H2O2
for 10 min (A) without or with preincubation of (B) 5 mM ionomycin (IM) for 5 min or (C) 40 mM BAPTA for 35 min, or appropriate vehicle. 15 mg of total protein lysates was
separated under nonreducing (β-ME) or reducing (not shown) conditions on 12% SDS–polyacrylamide gels and analyzed by Western blotting. The ratios of VILIP-1
monomer to dimer were calculated and data were normalized to control conditions (10 mM H2O2 for 10 min). Densitometric analysis7SEM of (A) ﬁve, (B) four, and (C) four
independent experiments is shown. (A) Dimerization of VILIP-1G2A in response to H2O2 was signiﬁcantly greater than dimerization of VILIP-1WT. (B) A trend to increased
dimerization of VILIP-1G2A preincubated with IM was observed. (C) H2O2-dependent dimerization of VILIP-1G2A was signiﬁcantly reduced according to preincubation with
BAPTA. (D) HEK293A cells were transfected with VILIP-1WT, VILIP-1G2A, VILIP-1C187A, or the empty pEF-BOS-EX vector. Cells were treated with either 10 mM H2O2 or vehicle
for 10 min. For immunolabeling, Cy2-coupled secondary antibody was used to label VILIP-1, which is shown in green. DAPI staining is shown in red. nnpo0.01.
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disulﬁde-linked dimerization after an oxidative stimulus. A similar
mechanismwas found to regulate the activity of ataxia-telangiectasia
mutated protein kinase in response to oxidative stress, where only
the disulﬁde-linked dimer was functionally active [56]. Although
only a relatively small proportion of VILIP-1 formed dimers, they
should be sufﬁcient to affect cellular fate if involved in a signal
transduction cascade. In this context it is noteworthy that VILIP-1 has
been shown to increase cellular cGMP levels by acting on guanylyl-
cyclase B [14,17], and conditions leading to dimerization of VILIP-1
were accompanied by elevated cGMP generation in vitro [12].
As a role for VILIP-1 dimers in the regulation of protein function
and cellular signaling demands a mechanism to remove the
dimers efﬁciently at the end of oxidative stimulation, we investi-
gated the thioredoxin system, which we found to be involved in
the remonomerization of VILIP-1. The thioredoxin system is an
important component of the antioxidative defense and involved in
the redox regulation of the cellular stress response [57]. As a
putative part of the so-called vitagene network [58,59], thioredox-
ins are a critical component to balance the redox equilibrium,
thereby promoting longevity [60,61]. This regulation may be
impaired by the chronic oxidative burden found in many neuro-
degenerative diseases that results in an imbalance of various
cellular systems such as the proteostasis network [62]. In addition,
thioredoxins are directly involved in redox signaling upon acute
oxidative stress by reducing and thus inactivating transcription
factors such as Yap1, which is activated by H2O2-mediated intra-
molecular disulﬁde bond formation [2]. The rapid dimer formation
of VILIP-1 under conditions of oxidative stress as well as the
efﬁcient remonomerization promptly after shifting the oxidative
environment toward reducing conditions meets the criteria for
redox sensors and makes the dimer a potential candidate execut-
ing a distinct cellular function in response to oxidative stress.
The role of calcium and the myristoyl residue in VILIP-1 dimer
formation
Disulﬁde bond-mediated dimerization of recoverin and VILIP-1
in vitro has been shown to strongly depend on calcium [12,52].
Therefore we investigated the role of calcium on dimer formation
of VILIP-1 in an intact cellular system. Myristoylated VILIP-1 has
been shown to bind two calcium ions under physiological condi-
tions [10]. Nonmyristoylated VILIP-1 binds calcium with higher
afﬁnity than the myristoylated protein, whereas the positive
cooperativity between the EF-hands is reduced [11], a phenom-
enon also evident in recoverin and neurocalcin δ [63,64]. We
found that calcium triggers redox-induced dimerization of VILIP-1
independent of protein myristoylation. This ﬁnding contradicted
our initial hypothesis that only the pool of calcium-bound VILIP-1
proteins attached to membranes via their myristoyl residues
should be sensitive to oxidant-induced dimerization. In fact, a
myristoyl-deﬁcient VILIP-1 mutant (VILIP-1G2A) dimerized to an
even higher extent than VILIP-1WT, and increased intracellular
calcium concentrations further enhanced the dimerization of
VILIP-1G2A. This could be explained by the increased afﬁnity of
nonmyristoylated VILIP-1 for calcium [11].
It has been shown that calcium binding to NCS induces major
conformational rearrangements beyond the extrusion of the
myristoyl residue, exposing a variety of hydrophobic residues
[6,8,11,65]. We propose that these structural changes make the
C-terminus of VILIP-1 more prone to dimerization. In this context
it would be possible that calcium-dependent VILIP-1 dimerization
in the cytoplasm is crucial for the subsequent relocalization of
VILIP-1 to cellular membranes. More recent studies, however,
discuss the role of the myristoyl residue in anchoring VILIP-1 to
cellular membranes more controversially and propose a model in
which the protein, also in the calcium-free state, is attached to
membranes via hydrophobic interactions independent of myris-
toylation [13]. In this model the myristoyl residue, after calcium
binding, serves either in enhancing membrane association or in
interacting with target proteins. This hypothesis is supported by
ﬁndings that recoverin associates with hydrophobic structures
upon calcium binding independent of its myristoylation [6] and
by a study in PC12 cells, in which nonmyristoylated VILIP-1 also
revealed a weak membrane association [50]. This concept is
supported by our data, in that a weak membrane staining was
observed for VILIP-1WT, VILIP-1G2A, and VILIP-1C187A also in the
absence of calcium. In line with this, it is possible that a pool of
membrane-associated VILIP-1 is particularly prone to dimerization
upon an oxidative stimulus, potentially because of the close
proximity of several VILIP-1 proteins at distinct membrane loci.
The role of Cys187 in modulating sensitivity of cells to oxidative stress
We found that transgenic expression of VILIP-1 in HEK293A
cells signiﬁcantly enhances sensitivity to physiologically relevant
concentrations of H2O2 upon long-term exposure. This property of
VILIP-1 was independent of its myristoylation. Interestingly, in
contrast to VILIP-1WT and VILIP-1G2A, VILIP-1 lacking the Cys187
residue critical for dimerization did not impair cell survival in
response to H2O2. From these ﬁndings, we conclude that dimer-
ization of VILIP-1 plays a critical role in the modulation of survival
upon long-term oxidative stress. The effect of VILIP-1 on cellular
survival has so far been investigated only under conditions of
calcium stress. Results from these studies are contradictory, as
VILIP-1 either protected from or enhanced calcium-induced cell
death in adrenocortical carcinoma cells or PC12 cells, respectively
[27,66]. Furthermore, hippocalcin, another NCS class B subfamily
member with 68% protein sequence identity to VILIP-1, protected
neuronal cell lines from calcium-induced apoptosis. The antiapop-
totic effect was mediated by the interaction with the neuronal
apoptosis inhibitory protein, which has been linked to the degen-
eration of motor neurons in spinal muscular atrophy [67–69].
Further studies are necessary to investigate the function of VILIP-1
Fig. 7. Impact of VILIP-1 dimerization on H2O2 sensitivity. 5000 HEK293A cells
transfected with VILIP-1WT, VILIP-1C187A, VILIP-1G2A, or empty vector per well were
treated with the indicated concentrations of H2O2 for 18 h before addition of MTT
for 3 h. For each transfection the mean absorption of six vehicle-treated wells was
normalized to 100%. The percentage of the mean absorption measured for each
H2O2 concentration compared to the mean absorption of vehicle-treated cells was
calculated. Cell viability was plotted against concentrations of H2O2. Shown is the
mean value of cell viability7SEM of four or more independently performed
experiments. Survival of cells upon treatment with H2O2 was signiﬁcantly impaired
in cells transfected with VILIP-1WT and VILIP-1G2A compared to both mock- and
VILIP-1C187A-transfected cells. Transfection efﬁciency between cells transfected
with different VILIP-1 constructs was comparable (not shown). npo0.05.
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dimerization in mediating the increased oxidative sensitivity of
cells upon VILIP-1 overexpression.
Dimerization and aggregation of VILIP-1 in ALS
ALS is a neurodegenerative disease that is characterized by
increased levels of oxidative stress and excitotoxicity that mutually
enhance each other [31]. We found that VILIP-1 dimers are present
in the spinal cord of mutant SOD1 animals from disease onset
onward. The observation that VILIP-1 dimerization makes cells
more sensitive to oxidative insults might provide a direct link
between oxidative stress, increased calcium levels, and the loss of
motor neurons. Furthermore, concomitant with disease onset,
VILIP-1 has been detected in protein aggregates. Although it is
tempting to assume that dimer formation by Cys187 is simply a
prerequisite of aggregate formation, our data suggest that both
processes could contribute to disease progression independently.
The investigation of VILIP-1 as a redox sensor and as a possible
mediator of toxicity in ALS is of particular interest as there is a
growing body of literature indicating that sensing the oxidative
status of the cell is a key event for the regulation of vitagenes that
include molecular chaperones and antioxidative enzymes such as
thioredoxins [70]. Nevertheless, the capacity for a continuous
adaptation to chronic oxidative stress is limited, particularly in
neurons affected by neurodegenerative diseases, and might there-
fore result in VILIP-1 dimerization. A speciﬁc role for VILIP dimers
for cell survival is supported by the observation that cysteine-
linked VILIP-1 dimers were detected only in affected tissues of
diseased animals, suggesting that in healthy control mice dimer
formation is strictly regulated. This is in line with our data
showing that VILIP-1 dimerization is completely reversible after
a short oxidative insult, indicating a functional relevance for VILIP-
1 dimer formation in redox signaling. In contrast, increasing
oxidative burden and elevated calcium levels over a long period
of time, as observed in ALS [31], might overwhelm the cellular
antioxidant defense systems. As a consequence, dimerized VILIP-1
accumulates and thus damages the cell. Recently, a similar
mechanism has been proposed for the transactivation response
DNA-binding protein of 43 kDa (TDP-43), a major disease protein
in ALS. TDP-43 is involved in redox signaling via cysteine oxidation
and subsequent relocation from the nucleus to the cytosol [71],
implying that cysteine oxidation is an upstream event in TDP-43
toxicity and that redox signaling is of broader relevance in ALS.
High-molecular-weight protein species detected in the
aggregate-enriched fraction by VILIP-1 antibodies suggest a rather
unorganized accumulation of proteins and are in contrast to the
Fig. 8. VILIP-1 dimerization in mouse models of ALS. (A–D) Lumbar spinal cord and cerebellum of nontransgenic mice and mice overexpressing hSOD1WT, hSOD1G93A, or
hSOD1G85R at onset or end stage of the disease were fractionated, yielding a total lysate, a soluble fraction, and an aggregate-enriched fraction. Shown is the medium
value7SEM of (A) ﬁve (spinal cord end stage), (B) three (spinal cord onset), or (C) three (cerebellum end stage) independent tissue fractionations of different mice. The total
lysate and the soluble fraction (both 5 mg) were separated on 15% SDS–polyacrylamide gels under nonreducing (β-ME) or reducing (þβ-ME; lower blot in (A); not shown
for (B) and (C)) conditions and transferred to nitrocellulose membranes. (D) To normalize for total expression level of VILIP-1, the band intensity of the VILIP-1 dimer was
divided by the band intensity of the VILIP-1 monomer. The VILIP-1 dimer/monomer ratio was signiﬁcantly greater in the spinal cords of SOD1mutant mice at disease onset
(SOD1G93A) as well as at disease end stage (SOD1G93A, SOD1G85R), but not in the cerebella of mice at disease end stage. npo0.05, nnpo0.01.
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very speciﬁc Cys187-mediated dimerization of VILIP-1 described
above. VILIP-1 oligomerization is induced upon calcium binding
in vitro and in vivo [11,72]. We propose that VILIP-1 interacts with
hydrophobic surfaces on protein aggregates by exposing the
myristoyl residue upon elevated calcium levels in the course of
disease. In a second step, aberrant disulﬁde crosslinking occurs
between proteins in close proximity. Such a two-step process has
also been described for mutant SOD1 aggregate formation [73]. As
a result, functional VILIP-1 levels are reduced and might thus
contribute to disease by a loss of function. In this context it is
noteworthy that whole genome expression proﬁling revealed
VILIP-1 mRNA to be downregulated in the motor cortex of sporadic
ALS patients [29].
In addition to ALS, VILIP-1 expression is reduced in AD patients
at the protein as well as the transcription level [26,74]. In addition,
VILIP-1 has been shown to be associated with amyloid plaques and
tangles [27]. In contrast, VILIP-1 levels are increased in the
cerebrospinal ﬂuid of AD patients and were suggested as an early
biomarker for cognitive decline [75–77]. With respect to our
ﬁndings that VILIP-1 dimerizes and aggregates in ALS, VILIP-1
might play multiple roles in a broader range of neurodegenerative
diseases.
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Table 1
VILIP-1 was revealed to be enriched in label-free LC–MSE mass spectrometric
analysis of ALS aggregates.
Genotype G93A/ntg
(x-fold)
G93A/WT
(x-fold)
G85R/ntg
(x-fold)
G85R/WT
(x-fold)
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Ubiquitin 2.56 2.39 2.26 2.11
VILIP-1 2.35 2.09 2.94 2.60
Insoluble fractions of control mice (ntg, SOD1WT) and SOD1G93A and SOD1G85R mice
at disease end stage were analyzed by label-free mass spectrometric analysis. VILIP-
1 was enriched in the insoluble fractions of both SOD1mutant mouse strains
compared to both ntg and SOD1WT mice. SOD1 and ubiquitin functioned as positive
controls. ntg, nontransgenic.
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